Literature DB >> 19442185

Neuropathic pain: models and mechanisms.

Michael F Jarvis1, Janel M Boyce-Rustay.   

Abstract

Advances in the characterization of pain signaling in recent years indicate that distinct neurophysiological and neurochemical mechanisms contribute to pain arising from injury to the nervous system (neuropathic pain). Tissue injury results in the release of pro-nociceptive mediators that sensitize peripheral nerve terminals (peripheral sensitization), leading to neurochemical and phenotypic alterations of sensory neurons and increased excitability of spinal cord dorsal horn neurons (central sensitization). In addition, the response of the nervous system to pain is not static, but is modulated by descending systems originating in the brain that can modulate pain thresholds. In this review, attention is given to the experimental modeling of neuropathic pain in preclinical studies. Recently, an increased understanding of the neurophysiological plasticity of the nervous system in response to chronic pain has led to the discovery and development of novel pharmacological interventions that may have clinical utility in treating neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442185     DOI: 10.2174/138161209788186272

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  20 in total

1.  Modulating pain in the periphery: gene-based therapies to enhance peripheral opioid analgesia: Bonica lecture, ASRA 2010.

Authors:  Srinivasa N Raja
Journal:  Reg Anesth Pain Med       Date:  2012 Mar-Apr       Impact factor: 6.288

Review 2.  H3 receptors and pain modulation: peripheral, spinal, and brain interactions.

Authors:  Lindsay B Hough; Frank L Rice
Journal:  J Pharmacol Exp Ther       Date:  2010-09-23       Impact factor: 4.030

Review 3.  Origins of Phantom Limb Pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 4.  Coping with Phantom Limb Pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

5.  A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain.

Authors:  R D Andó; B Méhész; K Gyires; P Illes; B Sperlágh
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

6.  Amelioration of diabetes and its complications by Manilkara zapota (L) P. Royen fruit peel extract and its fractions in alloxan and STZ-NA induced diabetes in Wistar rats.

Authors:  Pravin P Karle; Shashikant C Dhawale; Vijay V Navghare
Journal:  J Diabetes Metab Disord       Date:  2022-02-04

7.  Immortalized Bone Mesenchymal Stromal Cells With Inducible Galanin Expression Produce Controllable Pain Relief in Neuropathic Rats.

Authors:  Ke An; Yingpeng Cui; Xiaolong Zhong; Kunhe Li; Jinjun Zhang; Huiping Liu; Zhishuang Wen
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

8.  Alleviation of chronic pain following rat spinal cord compression injury with multimodal actions of huperzine A.

Authors:  Dou Yu; Devang K Thakor; Inbo Han; Alexander E Ropper; Hariprakash Haragopal; Richard L Sidman; Ross Zafonte; Steven C Schachter; Yang D Teng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

9.  Semi-mechanistic modelling of the analgesic effect of gabapentin in the formalin-induced rat model of experimental pain.

Authors:  A Taneja; I F Troconiz; M Danhof; O Della Pasqua
Journal:  Pharm Res       Date:  2013-10-05       Impact factor: 4.200

10.  Melatonin in antinociception: its therapeutic applications.

Authors:  Venkatramanujam Srinivasan; Edward C Lauterbach; Khek Yu Ho; Dario Acuña-Castroviejo; Rahimah Zakaria; Amnon Brzezinski
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.